NCT03254927 2023-04-03A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell CarcinomaCelldex TherapeuticsPhase 2 Terminated30 enrolled 17 charts
NCT00210470 2020-12-11A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck CancerBrooklyn ImmunoTherapeutics, LLCPhase 2 Completed27 enrolled 16 charts